Test Price
2,800 AED✅ Home Collection Available
VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Genetic Test comprehensively screens the VSX1 gene for variants linked to craniofacial anomalies and anterior segment dysgenesis syndrome. The analysis is performed using Next-Generation Sequencing (NGS) to detect single nucleotide variants and small insertions/deletions across the entire coding region.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Single nucleotide resolution with higher variant calling accuracy | Limited to targeted regions; may miss deep intronic or copy-number variants |
| Method | NGS – parallel massive sequencing | Sanger – sequential single-gene analysis |
| Turnaround Time | 3 to 4 Weeks | Often longer if multiple genes are tested |
Physician Insight & Safety Protocols
"This VSX1 NGS test is a powerful tool when craniofacial and anterior segment dysgenesis syndrome is suspected clinically, but results must always be correlated with a thorough physical exam and family history. Any genetic diagnosis should be integrated into a multidisciplinary care plan including paediatric specialists, genetic counsellors, and ophthalmologists."
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
🚨 Medication Safety & Advisory
Do not discontinue any prescribed medication without consulting your doctor. This genetic test identifies germline variants and does not reflect acute drug interactions. Always confirm with your treating physician before making any treatment changes.
Exclusion Criteria & Emergency Red Flags
- Active severe infection or acute illness – postpone sample collection until recovery.
- Minor status – parental or legal guardian consent mandatory per UAE Federal Law No. 2 of 2019.
- Seek immediate emergency care if the patient develops sudden loss of vision, severe craniofacial pain, or neurological deterioration; testing can be arranged after stabilization.
Patient FAQ & Clinical Guidance
1. What is the VSX1 gene craniofacial test?
This NGS test for the VSX1 gene accurately diagnoses craniofacial anomalies and anterior segment dysgenesis syndrome with precision. By analyzing the entire coding region using Next-Generation Sequencing, it detects single nucleotide variants and small insertions/deletions that may explain the patient’s congenital features.
2. How is the sample collected and what is the turnaround time?
A simple venous blood draw collected via our VIP Mobile Phlebotomy service is sufficient. The sample is transported under temperature-controlled cold chain. Results are available within 3 to 4 weeks.
3. Is this test covered by UAE health insurance?
Many UAE insurers reimburse this genetic test when clinically indicated and pre-authorized. We provide direct billing verification via WhatsApp at +971 54 548 8731. Please share your insurance details and our team will confirm coverage and out-of-pocket costs before scheduling.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
This test service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical and genetic data are handled with the highest security and confidentiality standards.
Clinical & Logistical Metadata
| Test Name | VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (Venipuncture) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Q87.0 (Congenital malformation syndromes predominantly affecting facial appearance) |
| LOINC Code | 21636-6 (Gene analysis) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians